Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.4%

2 terminated out of 37 trials

Success Rate

90.5%

+4.0% vs benchmark

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

16%

3 of 19 completed with results

Key Signals

3 with results90% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (16)
Early P 1 (1)
P 1 (2)
P 2 (3)
P 3 (1)
P 4 (3)

Trial Status

Completed19
Unknown7
Recruiting4
Not Yet Recruiting2
Terminated2
Withdrawn2

Trial Success Rate

90.5%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT07122284Completed

Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity

NCT07424313Not ApplicableCompleted

The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)

NCT04244877Phase 3Withdrawn

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

NCT06223685Not ApplicableCompleted

The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin

NCT07215676Not ApplicableNot Yet Recruiting

A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth

NCT05967871Phase 1RecruitingPrimary

Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth

NCT07019142Not ApplicableCompleted

High-fat Diet (HFD) and Small Intestinal Microbiome

NCT06298409Phase 1RecruitingPrimary

Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®

NCT06317441Not ApplicableRecruitingPrimary

The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms

NCT01822470Enrolling By Invitation

Small Intestinal Bacterial Overgrowth: A Prospective Registry

NCT06483360Not Yet RecruitingPrimary

Methane and Hydrogen Breath Test for the Diagnosis of Small Intestinal Bacterial Overgrowth

NCT04506593Recruiting

Indiana University Gastrointestinal Motility Diagnosis Registry

NCT02470780Phase 2Completed

Treating Bacterial Overgrowth in Parkinson's Disease

NCT04910815Not ApplicableUnknownPrimary

Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.

NCT05915767Not ApplicableCompletedPrimary

Therapeutic Effect of Olive Leaf Tea on SIBO

NCT06162702Not ApplicableCompletedPrimary

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

NCT05122520CompletedPrimary

Hydrogen and Methane Breath Test Questionnaire

NCT04841980Phase 4Unknown

Rifaximin Therapy vs Low FODMAP Diet In IBS

NCT05765994CompletedPrimary

Small Intestinal Bacterial Overgrowth in Critically Ill Patients

NCT04316806Not ApplicableTerminated

Effect of a Probiotic Formula on Reducing SIBO in IBS Patients

Scroll to load more

Research Network

Activity Timeline